Skip to main content
. 2021 Oct 19;13(10):3665. doi: 10.3390/nu13103665

Figure 1.

Figure 1

BBR-PP effectiveness on the primary and secondary endpoints on insulin resistance and the glycemic profile. * p ≤ 0.005; ** p < 0.0005.